OGLIARI, FRANCESCA RITA
OGLIARI, FRANCESCA RITA
Facoltà di Medicina e Chirurgia
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies
2023-01-01 Lazzari, C.; Yacoub, M. R.; Campochiaro, C.; Bulotta, A.; Palumbo, D.; Ogliari, F. R.; Dagna, L.; Marchesi, S.; Ponzoni, M.; Gregorc, V.
Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle?
2023-01-01 Venanzi, F. M.; Bini, M.; Nuccio, A.; De Toma, A.; Lambertini, M.; Ogliari, F. R.; Oresti, S.; Vigano, M. G.; Brioschi, E.; Polignano, M.; Naldini, M. M.; Riva, S.; Ferrara, M.; Fogale, N.; Damiano, G.; Russo, V.; Reni, M.; Veronesi, G.; Foggetti, G.; Conforti, F.; Bulotta, A.; Ferrara, R.
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies
2023-01-01 Nuccio, A.; Viscardi, G.; Salomone, F.; Servetto, A.; Venanzi, F. M.; Riva, S. T.; Oresti, S.; Ogliari, F. R.; Viganò, M.; Bulotta, A.; Cameron, R.; Esposito, A.; Hines, J.; Bianco, R.; Reni, M.; Cascone, T.; Garassino, M. C.; Torri, V.; Veronesi, G.; Cinquini, M.; Ferrara, R.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies | 1-gen-2023 | Lazzari, C.; Yacoub, M. R.; Campochiaro, C.; Bulotta, A.; Palumbo, D.; Ogliari, F. R.; Dagna, L.; Marchesi, S.; Ponzoni, M.; Gregorc, V. | |
Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle? | 1-gen-2023 | Venanzi, F. M.; Bini, M.; Nuccio, A.; De Toma, A.; Lambertini, M.; Ogliari, F. R.; Oresti, S.; Vigano, M. G.; Brioschi, E.; Polignano, M.; Naldini, M. M.; Riva, S.; Ferrara, M.; Fogale, N.; Damiano, G.; Russo, V.; Reni, M.; Veronesi, G.; Foggetti, G.; Conforti, F.; Bulotta, A.; Ferrara, R. | |
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies | 1-gen-2023 | Nuccio, A.; Viscardi, G.; Salomone, F.; Servetto, A.; Venanzi, F. M.; Riva, S. T.; Oresti, S.; Ogliari, F. R.; Viganò, M.; Bulotta, A.; Cameron, R.; Esposito, A.; Hines, J.; Bianco, R.; Reni, M.; Cascone, T.; Garassino, M. C.; Torri, V.; Veronesi, G.; Cinquini, M.; Ferrara, R. |